Dr. Yanguang (Carter) Cao is an Associate Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. With a Ph.D. in Pharmaceutical Sciences and a B.S. in Pharmacology, he has extensive expertise in Quantitative Systems Pharmacology (QSP), Pharmacokinetics, Pharmacodynamics, and Computational Oncology and Immunology. Dr. Cao leads a dynamic and diverse team of experts working in the field of QSP and Model-Informed Drug Discovery and Development, with a particular focus on antibody-based therapeutics. He has over 70 peer-reviewed papers published as of now. His group is currently funded by the National Institute of Health and the Food and Drug Administration.